Quantcast

Latest Cumberland Pharmaceuticals Inc. Stories

2014-07-22 16:27:13

NASHVILLE, Tenn., July 22, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release second quarter 2014 financial results after the market closes on Tuesday, August 5, 2014. A conference call and live Internet webcast will be held on Tuesday, August 5, 2014, at 4:30 p.m. Eastern Time to discuss the results. http://photos.prnewswire.com/prnvar/20140505/84325 To participate in the call, please dial 877-303-1298 (for U.S. callers) or...

2014-05-13 16:28:49

- Launched promotional efforts to support Omeclamox®-Pak NASHVILLE, Tenn., May 13, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced first quarter 2014 financial results. During the quarter the Company returned to profitability, launched two new products, and continued to maintain positive cash flow from operations....

2014-05-07 08:31:48

-Vaprisol marks new product for hospital sales force NASHVILLE, Tenn., May 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced the launch of its active promotional campaign to support its new Vaprisol(®) product. Cumberland will promote Vaprisol across the United States through its hospital sales force. A National Sales Meeting was convened this week to officially launch active promotion and other efforts to support the brand. Cumberland acquired...

2014-05-06 08:33:35

NASHVILLE, Tenn., May 6, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) and China's Gloria Pharmaceuticals Co. (SHE: 002437) announced today a joint research & development initiative. Each company has made a $1 million investment in Cumberland Emerging Technologies ("CET"), which is majority owned by Cumberland and partners with academic research centers to develop promising biopharmaceutical technologies. The new funds will be used to accelerate development...

2014-04-29 16:32:16

NASHVILLE, Tenn., April 29, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2014 financial results after the market closes on Tuesday, May 13, 2014. A conference call and live Internet webcast will be held on Tuesday, May 13, 2014, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of...

2014-03-07 16:22:47

NASHVILLE, Tenn., March 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the efficacy and safety of Caldolor(®) (ibuprofen) Injection will be presented at the Pediatric Anesthesiology 2014 conference in Fort Lauderdale, Florida. The pediatric study met its primary endpoint demonstrating that Caldolor was associated with a statistically significant reduction in temperature within the first 2 hours of...

2014-03-04 16:25:50

- Acquired Vaprisol® from Astellas Pharma US, Inc. NASHVILLE, Tenn., March 4, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced fourth quarter and annual 2013 financial results. The Company also recently announced the acquisition of Vaprisol, a marketed critical care product from Astellas Pharma US, Inc. Net Revenue: For the three months ended December 31,...

2014-03-03 08:31:51

NASHVILLE, Tenn., March 3, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol(®) from Astellas Pharma US, Inc. Vaprisol(®) is a patented, prescription brand indicated to raise serum sodium levels in hospitalized patients with hyponatremia. The product was developed and registered by Astellas and was commercially launched in 2006. It is one of two branded prescription products indicated for the treatment of hyponatremia....

2014-02-27 16:27:17

NASHVILLE, Tenn., Feb. 27, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release 2013 year-end financial results after the market closes on Tuesday, March 4, 2014. A conference call and live Internet webcast will be held on Tuesday, March 4, 2014, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related